30-Second Takeaway
- Delayed recognition of post-colectomy organ-space infection sharply increases complications, reoperation, length of stay, and failure-to-rescue.
- Postoperative gut barrier failure, dysbiosis, and inflammasome activation may mechanistically drive anastomotic leak and other inflammatory complications.
- Early recurrence after curative colorectal cancer surgery predicts substantially worse post-recurrence survival than later relapse.
- Postoperative spikes and variability in circulating DNA can confound early ctDNA-based minimal residual disease interpretation after colon resection.
- Early-onset colorectal neoplasia and survivors show distinct risk and morphology profiles, warranting tailored endoscopic and survivorship strategies.
Week ending February 14, 2026
Leaks, recurrence biology, and long-term trajectories in colorectal surgery
Delayed organ-space SSI after colectomy sharply raises failure-to-rescue
This VA cohort included 39,175 colon resections with organ-space SSI in 3.1%, used as a surrogate for anastomotic leak. Of 1,227 organ-space SSIs, 31.1% were diagnosed after sepsis and classified as delayed. Delayed versus early diagnosis was associated with more complications (3.0 vs 1.7), higher reoperation probability (62.1% vs 40.3%), and longer stay (22.6 vs 17.6 days). Failure-to-rescue was markedly higher with delayed diagnosis (7.8% vs 2.2%). These data support protocolized leak surveillance and rapid escalation when sepsis appears after colon resection.
Review links dysbiosis, barrier disruption, and inflammasomes to anastomotic leak
This review summarizes evidence connecting surgical trauma, dysbiosis, and epithelial barrier failure to anastomotic leak after colorectal surgery. It emphasizes inflammasomes, including NLRP3, NLRC4, and particularly NLRP6, as mediators of postoperative intestinal inflammation. Barrier disruption and altered permeability allow bacterial translocation, amplifying inflammatory cascades that may impair anastomotic healing. The authors propose that microbiota composition, permeability, and inflammasome activity could help identify high-risk patients and guide preventive strategies.
Macrophage PDGFB–PDGFRB signaling in FADS1⁺ cells drives colorectal liver metastasis
This multiomics study defined molecular subtypes and microenvironmental drivers of colorectal cancer liver metastasis using 1,156 metastasis-associated genes. Three subtypes showed distinct immunometabolic profiles and prognoses, with one characterized by immune activation and signaling dysregulation having the worst survival. Mechanistically, SPP1⁺ macrophages secreted PDGFB, activating PDGFRB signaling in FADS1⁺ tumor cells and inducing epithelial–mesenchymal transition. Single-cell transcriptomics, genetic perturbation, and coculture experiments validated this macrophage–tumor PDGFB–PDGFRB axis as pro-metastatic. The pathway represents a potential therapeutic target to limit liver metastasis and associated immune resistance.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.